Clinical Trial Update: GCPGC in Chemotherapy-induced Neutropenia [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial of GCPGC for chemotherapy-induced neutropenia is reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• GCPGC

Snippet

Sponsor: Green Cross Corporation | Conditions: Chemotherapy Induced Neutropenia | Phase 2, Phase 3 | Status: COMPLETED